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Abstract: Fetal sex has been identified as an important factor influencing pregnancy outcomes,
but its impact on fetal heart rate (FHR) variability in uncomplicated pregnancies is still unclear.
The objective of the study was to assess short-term variability (STV) and other computerized
cardiotocography (cCTG) parameters in relation to fetal sex during fetal antepartum surveillance.
We retrospective compared cCTG parameters of male and female fetuses in uncomplicated singleton
pregnancies at term. In addition to univariate analysis, a multivariate analysis was performed
taking into account maternal characteristics. A total of 689 cCTG recordings were analyzed: 335
from male fetuses and 354 from female fetuses. Analysis of cCTG results by fetal sex showed no
significant difference in percentage of signal loss, number of contractions, movements, accelerations
and decelerations, long-term variability (LTV), and STV at both uni-and multivariate analysis. There
was a statistically significant difference for baseline FHR at the univariate analysis, which was not
confirmed by a multivariate analysis. Our results suggest that fetal sex did not affect cCTG parameters
in uncomplicated term singleton pregnancies, and therefore it does not need to be taken into account
when interpreting cCTG in physiological conditions.
Keywords: fetal sex; cardiotocography; fetal heart rate; computerized analysis; uncomplicated
pregnancy
1. Introduction
Fetal sex has been identified as an important factor influencing both fetal and maternal outcome.
The hormonal secretion of various substances during pregnancy is influenced by fetal sex [1–3].
Specifically, some placental functions are sex-specific with different pathways of gene expression,
proteins, and steroids according to the sex of the fetus. This sex-specific difference in the feto-placental
immune system results in the adoption of different strategies by males and females to face the same
adverse maternal environment. In general, males have a greater risk of adverse outcome because of
minimal placental adjustment with the aim of ensuring continued growth [4]. Many studies support
this statement, showing an increased risk of preterm birth, cesarean delivery, failed induction of labor,
perinatal mortality, and gestational diabetes in pregnant women with male fetuses [4,5]. Conversely,
the multiple placental adaptations in gene and protein expression in female fetuses result in increased
survival, at the expense of reduced fetal growth and resulting in an increased risk of developing
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gestational hypertensive disorders [4]. Thus, placental function seems to be sensitive to fetal sex,
and the feto–maternal interaction therefore seems to be reflected in a placental response that differs
between males and females. Given the difference in pregnancy outcome between male and female
fetuses, various authors have examined fetal heart rate (FHR) variability and other parameters of fetal
cardiotocography (CTG) in order to identify differences between sexes. However, most of these studies
assessed FHR differences during labor or in particular conditions related to individual fetal behavioral
states [6–9]. Therefore, findings of these studies cannot be generalized to the whole antepartum period.
Moreover, previous studies often examined indices of the FHR that are difficult to reproduce, such as
power spectral density (PSD) and approximate entropy (ApEn) [6,7,10,11].
The objective of this study was to assess short-term variability (STV) and other additional
computerized CTG (cCTG) parameters in relation to fetal sex during fetal antepartum surveillance in a
large population of uncomplicated singleton pregnancies at term.
2. Materials and Methods
We conducted a retrospective analysis of computerized CTG tracings in women with
uncomplicated singleton pregnancies between 37 and 40 weeks of gestation, who were referred
to the outpatient clinic of the Careggi University Hospital in Florence, Italy, between January and
December 2014. The last tracing of male and female fetuses during the antepartum period, before labor,
was selected. The regional public health care offers fetal antepartum surveillance in the third trimester
to all pregnant women. In our hospital, it is common to do a cCTG even in low-risk pregnancies after 37
weeks of gestation. This study was approved by the Local Ethics Committee. We adopted the definition
of Chappell and colleagues for uncomplicated pregnancy: “a normotensive pregnancy, delivered at
>37 weeks, resulting in a live born baby who was not small for gestational age, and did not have any
other significant pregnancy complications” [12]. We have complied with the World Medical Association
Declaration of Helsinki regarding ethical conduct of research involving human subjects. Results of
cCTG recordings were obtained from the Sonicaind FM 8000 and matched with the electronic patient
records (Argos 3.34 Dedalus SpA, Florence, Italy). External CTG was used for monitoring the FHR for
20 min and the activity of the uterine muscle by two transducers placed on the maternal abdomen: one
above the fetal heart level and the other at the uterine fundus. When evaluating cCTG data obtained
from the Sonicaid FM800E (Huntleigh Healthcare Ltd, Cardiff, UK), the following information was
evaluated: baseline FHR (expressed in beats per minute), number of uterine contractions, number of
accelerations and/or decelerations, duration of episodes of long-term variability (LTV) in minutes,
STV in milliseconds, percentage of signal loss, and number of fetal movements. The FHR parameters
considered in the study was defined according to FHR monitoring guidelines, Sonicaid computer
systems [13]. Only one tracing per fetus was included (the last tracing before the onset of labor).
Data on mode of delivery and neonatal outcome were also collected and compared between male
and female sex. Categorical variables were compared using the chi-squared test, and continuous
variables were compared using the Mann–Whitney test, given the non-parametric distribution of the
data. For multivariate analysis we used a multiple linear regression model with a binary outcome
(dependent variable) and several predictors (independent variables). Specifically, the multivariate
analysis pooled together the cCTG results to correct for possible confounders during data interpretation.
The independent variables were the following: baseline FHR, number of uterine contractions, number
of accelerations, number of decelerations, LTV (min), STV (ms), signal loss (%), and number of fetal
movements. The binary outcome was represented by fetal sex (male vs female). The software used for
the statistical analysis was SPSS 23.0 (IBM, Chicago, IL, USA). The last antepartum computerized CTG
tracing of male and female fetuses in uncomplicated singleton pregnancies was included. Exclusion
criteria were: gestational age <37 weeks or after 41 complete weeks, congenital malformations, maternal
comorbidities, or pregnancies complicated by obstetrical pathological conditions such as hypertensive
disorders, fetal growth restriction, and gestational diabetes.
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3. Results
A total of 689 cCTG recordings, obtained from 689 pregnancies, were analyzed, with 335 from
male fetuses and 354 from female fetuses. Maternal characteristics are presented in Table 1. Median
gestational age at cCTG recording was the same between male and females fetuses. Four cases of males
had a missing description of maternal obstetric history, 3 males had missing ethnicity value; 4 cases
of females had missing obstetric history and maternal ethnicity. A statistically significant difference
was found in the ethnicity of the patients at the univariate analysis, which was not confirmed by
multivariate linear regression (data not shown). Analysis of cCTG results by fetal sex showed no
significant difference in percentage of signal loss, number of contractions, movements, accelerations
and decelerations, LTV, and STV at both uni- and multivariate analysis. There was a statistically
significant difference for the baseline FHR at the univariate analysis (Table 2, p < 0.05), which was
not confirmed by a multivariate analysis. Delivery mode and neonatal outcome of males and the
females are summarized in Table 3. Mean birth weight was significant higher in males than in females
(p < 0.05). There was no difference in the Apgar score, umbilical cord pH, base excess (BE), gestational
age at delivery, and mode of delivery between sexes.
Table 1. Maternal characteristics according to fetal sex.
Male Fetuses (n = 335) Female Fetuses (n = 354) p-Value
Gestational age at cCTG (weeks) 40 (38–40) 40 (38–40) 0.89
Maternal age (years) 34 (29–37) 33 (30–37) 0.57
Pre-pregnancy BMI (kg/m2) 22.1 (19.9–24.7) 22 (20–24.4) 0.91
Maternal obstetric history
Nulliparous 199 (60.1%) 204 (58.3%)
Parous with one previous birth 111 (33.5%) 116 (33.1%) 0.54
Parous with ≥2 previous births 21 (6.3%) 30 (8.6%)
Maternal ethnicity—n (%)
Caucasian 287 (86.4%) 280 (80%) 0.03
Latin American 9 (2.7%) 23 (6.6%)
African 19 (5.7%) 18 (5.1%)
Asian 17 (5.1%) 29 (8.3%)
cCTG, computerized cardiotocography; BMI, body mass index. Continuous variables are expressed with median,
25th–75th percentile; categorical variables are expressed with n, percentage.









Baseline FHR (bpm) 135 (128–141) 136 (130–142) 0.03 0.25
Uterine contractions (n.) 1 (0–2) 1 (0–2) 0.82 0.62
Accelerations (n.) 3 (2–5) 3 (2–5) 0.13 0.35
Decelerations (n.) 0 (0–0) 0 (0–0) 0.21 0.29
LTV (minutes) 8 (6–10) 8 (6–10) 0.18 0.82
STV (ms) 10.1 (8.1–12.5) 9.65 (8.1–11.7) 0.05 0.32
Signal loss (%) 1 (0–4) 1 (0–4) 0.35 0.76
Fetal movements (n.) 10 (4–24) 10.5 (2–28) 1 0.48
bpm, beats per minute; FHR, fetal heart rate; LTV, long-term variability; STV, short-term variability. Continuous
variables are expressed with median, 25th–75th percentile. *multivariate analysis, pooling together maternal
characteristics (Table 1) and CTG results.
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Table 3. Neonatal outcome according to fetal sex.
Male Fetuses Female Fetuses p-Value
Birth weight (g) 3500 (3200–3817) 3360 (3135–3700) 0.002 *
Apgar score at 1 min 9 (9–9) 9 (9–9) 0.074 *
Apgar score at 5 min 10 (9,10) 10 (9,10) 0.687 *
Umbilical cord pH 7.3 (7.2–7.3) 7.3 (7.2–7.3) 0.388 *
Base excess −4.3 (−7.3–−2.0) −3.9 (−6.5–−1.6) 0.082 *
Mode of delivery—n (%)
Vaginal delivery 248 (74%) 280 (79.1%) 0.116 **
Cesarean delivery 87 (26%) 74 (20.9%)
Continuous variables are expressed with median, 25–75 percentile. * Mann–Whitney test. ** chi-squared test.
4. Discussion
Current available evidence shows that cardiotocography performed in specific conditions is
affected by fetal sex. Bernardes et al. studied specific indices of linear and complex FHR variability
in relation to fetal behavioral states, during the antepartum period of normal term pregnancies,
and found significant sex differences [6]. The same authors found more marked changes in FHR
in female fetuses, in relation to progression of labor and during the minutes preceding delivery,
particularly in fetuses with academia [7]. Similar results were reported when computerized CTG
was used for FHR analysis during the last hour before delivery in term fetuses [8]. Fetal heart rate
changes that differ between male and female fetuses have also been observed after maternal chocolate
intake [14]. Additionally, gestational age should be considered when defining reference ranges for
FHR indices in systems of computerized analysis. In a large retrospective study using antepartum
FHR recordings of male and female fetuses, with normal pregnancy outcome, mean FHR decreased
significantly throughout gestation, whereas most variability indices increased. Gestational ages of
this study ranged between 25 and 40 weeks [11]. In our study we considered only uncomplicated
singleton pregnancies between 37 and 40 weeks of gestation, reducing significantly the possible
influence of gestational age on FHR variability in both sexes. A retrospective cross-sectional study
using antepartum tracing of singleton fetuses with normal pregnancy outcomes provided reference
values for CTG parameters throughout pregnancy from 24 to 40 weeks of gestation. FHR parameters
were evaluated throughout pregnancy by comparing four different gestational age intervals: 24–27
weeks, 28–31 weeks, 32–35 weeks, and 36–40 weeks. Comparisons were made separately in female
and male fetuses for variables showing statistical significant differences between these two groups [15].
We compared FHR parameters between male and female fetuses in a range of 37–40 weeks reporting
no statistical difference.
We examined cCTG parameters of male and female fetuses in singleton pregnancies during the
antepartum period, before labor, without focusing on a particular maternal or fetal condition, in order
to clarify the influence of fetal sex on CTG results. Only uncomplicated term pregnancies have been
included to avoid confounders such as pathological conditions or preterm gestational age.
No significant difference was found in most of the computerized CTG parameters, such as
number of accelerations and/or decelerations, duration of episodes of LTV, STV, and number of fetal
movements, at either uni-and multivariate analysis. Although there was a statistically significant
difference in the baseline FHR between male and female fetuses at univariate analysis, this was not
confirmed at multivariate analysis. Our results are consistent with a previous prospective study
in which the authors found no sex difference in FHR variation using cCTG analysis. However, in
that study the number of fetuses observed was extremely limited (44 males and 35 females) and the
gestational age at monitoring was lower than the one we used (median 35 weeks) [16].
Cardiotocography is widely used to assess fetal well-being and the comparison of cCTG versus
traditional CTG showed a significant reduction in perinatal mortality with the computerized analysis
(RR 0.20, 95% CI 0.04 to 0.88) [17]. The STV is one of the most used indicator of fetal metabolic status,
as it correlates with a condition of fetal acidemia when significantly reduced [18].
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Our results suggest that no sex-specific variations of fetal heart parameters are present in low
risk pregnancies at term, when monitored outside the intrapartum period. Probably, the influence of
fetal sex is mostly observed in complicated pregnancies, where sex has been observed to influence
placental response to pathological conditions such as gestational hypertensive disorders, fetal growth
restriction, and gestational diabetes [4]. Data on mode of delivery and neonatal outcome were similar
in both male and female groups in our study, except for a higher birth weight in male fetuses.
The strength of our study is the accurate selection of the cases, since we excluded gestational
disorders, low gestational age, maternal and fetal diseases, and peculiar times of pregnancy such as
labor, which could have affected the CTG variables regardless of the sex of the fetus. However, it is
possible that the development of some pathological conditions during pregnancy is associated with
detection of differences in cCTG parameters between males and females which may not have been
captured by our study design. Another limitation is that sex differences probably were not found
because of the FHR parameters considered or for the type of computer system used for CTG analysis.
Additionally, different definitions of the main FHR parameters are present according to the current
FHR monitoring guidelines [13,19–21].
However, a computer system that follows the standard definitions of CTG features was used,
providing an objective, quantitative, and consistent assessment of the CTG reading.
In conclusion, our results suggest that fetal sex does not affect cCTG parameters in uncomplicated
term singleton pregnancies, and therefore it does not need to be taken into account when interpreting
cCTG in physiological conditions. Conversely, future studies should investigate the impact of sex on
cCTG parameters in pathological pregnancies, especially at earlier gestational ages.
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